SCHEMBL31152363

SCHEMBL31152363

O=C1CC=Nc2ccnn21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13500694 0.76 — —
SCHEMBL1199564 0.58 — —
SCHEMBL6889392 0.57 — —
SCHEMBL14397970 0.56 ALDH1A1 (0.33) —
SCHEMBL3980439 0.55 MAPT (0.36) —
SCHEMBL16291487 0.54 — —
SCHEMBL7916659 0.52 — —
SCHEMBL16751261 0.51 — —
SCHEMBL2432407 0.47 — —
SCHEMBL12973030 0.47 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4692089-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AS AAK1 INHIBITOR Alicorn Pharmaceutical Co., Ltd. (CN) 2026-02-11 — — EP disclosed
CN-118772152-A Azacyclic compounds as AAK1 inhibitors 艾立康药业股份有限公司 2024-10-15 — — CN disclosed
WO-2024207945-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AS AAK1 INHIBITOR 艾立康药业股份有限公司 2024-10-10 — — WO disclosed
Send feedback